Effect of MD1003 in Amyotrophic Lateral Sclerosis
Clinical trial NCT03114215 · COMPLETED
Trial details
- NCT number
- NCT03114215
- Sponsor
- MedDay Pharmaceuticals SA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-29
- Primary completion
- 2017-06-12
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.